Enliven Therapeutics, Inc.

ELVN · XNAS

CIK 1672619fmd_0DVT71DQ3FGGS7A65WVX3K2746Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 31 periods

Ratios computed from the standardized statements. Select a value to open its proof.